|
|
 |
| |
NxStage Commends Clinical Journal of the American Society of Nephrology (CJASN) Article Urging Greater Use of Home Hemodialysis
LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 in the Clinical Journal of the American Society of Nephrology (CJASN) in which leading nephrologists advocate for broadened access to home hemodialysis based on its proven benefits and successful use by thousands of patients. Within the paper, "How to Overcome Barriers and Establish a Successful Home HD Program," the authors also recognize the contribution of the NxStage System One™, the world's first and only truly portable hemodialysis machine, in making home hemodialysis a viable option for patients as a result of its simplicity and clinical efficacy.
|
NxStage Home Hemodialysis Advocate
Brian Hess Honored by
American Association of Kidney Patients |
 |
|
|
|
NxStage aims to lead the way with innovative technologies and product designs that simplify the delivery of renal therapies to patients with both acute and chronic kidney failure.
For ESRD patients, NxStage innovations make daily home dialysis more practical, helping patients pursue the health benefits of more frequent therapy, while enabling them to maintain a more normal lifestyle. NxStage innovations even give patients the freedom to travel, without disrupting their treatment schedule.
In acute kidney failure and critical care settings, NxStage innovations offer clinicians multiple, truly portable, flexible therapy options, while reducing the need for staff intervention.
Read NxStage Press Releases
|
|
Free Patient Information Kit
The Life-Changing Benefits of Daily Home Hemodialysis
With the NEW “Being Me Again” DVD featuring stories of five NxStage Patients |
|
BEING ME AGAIN:
Lives transformed by Daily Home Hemodialysis
Taking responsibility for your health and wellbeing can mean different things to different people. In this video, five patients who are doing daily home hemodialysis with the NxStage® System One™ share their stories and the benefits they have experienced. It also showcases three nephrologists who have witnessed these benefits in their patients. |
|
Download the NxStage Freedom Study PDFs |
 |
Natural disasters as well as other non-medical emergency situations can pose significant, unique risks to people with chronic kidney disease. As a home dialysis patient, you need to be extra prepared for a possible emergency. Television or radio can give you advance warning of a major storm, but other emergencies can happen without warning. Without access to power, water, dialysis supplies and transportation, your life can be in danger. |
More on NxStage Home Hemodialysis
NxStage: NIH Study Published in New England Journal of Medicine Adds to Growing Body of Evidence in Support of More Frequent Hemodialysis
LAWRENCE, Mass., Sept. 23, 2011 /PRNewswire via COMTEX/ -- NxStage Medical, Inc, a leading manufacturer of innovative dialysis products, today commented on the just-released findings of an NIH sponsored study which shows that event rates, including mortality, were significantly higher for patients following the long (2-day) interdialytic interval associated with a three times per week dialysis schedule ("conventional dialysis"). The study entitled "Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis," compared the rates of death and cardiovascular-related hospital admissions on the day after the 2-day interdialytic interval with rates on other days for 32,065 in-center hemodialysis patients from the United States Renal Data System (USRDS) database. |
|
|
|
|
|
NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner
LAWRENCE, Mass., June 17, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, CEO, received the Ernst & Young Entrepreneur of the Year ® 2011 New England Award in the Medical Devices category. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Mr. Burbank was selected by an independent panel of judges, and the award was presented at a gala event at the Renaissance Boston Waterfront Hotel on June 15, 201 |
LAWRENCE, Mass., April 27, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Michael Miller, Jr., former Senior Vice President and General Manager of the Cardiac Care Business at Philips Healthcare, has joined the NxStage senior management team in the newly-created position of President, International.
|
Short Daily Hemodialysis Reduces Common Symptom in Dialysis Patients
Washington, DC (March 11, 2011) — For dialysis patients, performing daily dialysis at
home can help alleviate sleep problems related to restless legs syndrome (RLS),
according to a study appearing in an upcoming issue of the Clinical Journal of the
American Society of Nephrology (CJASN)
|
Connor A, Lillywhite R, Cooke, MW
The Campaign for Greener Healthcare, Oxford, UK Department of Renal and General Medicine, Dorset County Hospital, Dorchester, UK Research Scientist, Warwick HRI, University of Warwick, Coventry, UK Professor of Emergency Medicine, Warwick Medical School, University of Warwick, Coventry, UK.
Climate change presents a global health threat. However, the provision of healthcare, including dialysis, is associated with greenhouse gas emissions.....
|
upated October 6 2012
hemodialysis Keywords | hemodialysis Tags | hemodialysis Keyword Cloud
| |
|
|
|
